FKBP-rapamycin inhibits a cyclin-dependent kinase activity and a cyclin D1-Cdk association in early G1 of an osteosarcoma cell line

Targets for Cell Cycle Arrest by the Immunosuppressant Rapamycin in Yeast

Heitman, J., Movva, N. R., & Hall, M. N. (1991) · Science · doi:10.1126/science.1715094 · Cited by 2,055

Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinases

Chung, J., Kuo, C. J., Crabtree, G. R., & Blenis, J. (1992) · Cell · doi:10.1016/0092-8674(92)90643-q · Cited by 1,151

Formation and Activation of a Cyclin E-cdk2 Complex During the G 1 Phase of the Human Cell Cycle

Koff, A., Giordano, A., Desai, D., Yamashita, K., Harper, J. W., Elledge, S. J., Nishimoto, T., Morgan, D. O., Franza, B. R., & Roberts, J. M. (1992) · Science · doi:10.1126/science.1388288 · Cited by 1,043

D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA

Xiong, Y., Zhang, H., & Beach, D. (1992) · Cell · doi:10.1016/0092-8674(92)90518-h · Cited by 1,021

Functional interactions of the retinoblastoma protein with mammalian D-type cyclins

Ewen, M. E., Sluss, H. K., Sherr, C. J., Matsushime, H., Kato, J.-Y., & Livingston, D. M. (1993) · Cell · doi:10.1016/0092-8674(93)90136-e · Cited by 1,010

A family of human cdc2‐related protein kinases.

Meyerson, M. M., Enders, G. H., Wu, C. L., Su, L., Gorka, C., Nelson, C. E., Harlow, E., & Tsai, L. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05360.x · Cited by 925

Identification and properties of an atypical catalytic subunit (p34PSK-J3/Cdk4) for mammalian D type G1 cyclins

Matsushime, H., Ewen, M. E., Strom, D. K., Kato, J.-Y., Hanks, S. K., Roussel, M. F., & Sherr, C. J. (1992) · Cell · doi:10.1016/0092-8674(92)90360-o · Cited by 897

Target of rapamycin in yeast, TOR2, is an essential phosphatidylinositol kinase homolog required for G1 progression

Kunz, J., Henríquez, R., Schneider, U., Deuter‐Reinhard, M., Movva, N. R., & Hall, M. N. (1993) · Cell · doi:10.1016/0092-8674(93)90144-f · Cited by 859

Physical interaction of the retinoblastoma protein with human D cyclins

Dowdy, S. F., Hinds, P. W., Louie, K., Reed, S. I., Arnold, A., & Weinberg, R. A. (1993) · Cell · doi:10.1016/0092-8674(93)90137-f · Cited by 746

Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin.

Bierer, B. E., Mattila, P. S., Standaert, R. F., Herzenberg, L. A., Burakoff, S. J., Crabtree, G. R., & Schreiber, S. L. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.23.9231 · Cited by 706

Design and evaluation of 3-aminopyrazolopyridinone kinase inhibitors inspired by the natural product indirubin

Smyth, L. A., Matthews, T. P., & Collins, I. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.03.069 · Cited by 19

Inhibition of the Mr 70,000 S6 kinase pathway by rapamycin results in chromosome malsegregation in yeast and mammalian cells

Bonatti, S., Simili, M., Galli, A., Bagnato, P., Pigullo, S., Schiestl, R. H., & Abbondandolo, A. (1998) · Chromosoma · doi:10.1007/s004120050335 · Cited by 19

Comparative effects of FK-506, rapamycin and cyclosporin A, on the in vitro differentiation of dorsal root ganglia explants and septal cholinergic neurons

Carreau, A., Gueugnon, J., Bénavidès, J., & Vigé, X. (1997) · Neuropharmacology · doi:10.1016/s0028-3908(97)00160-3 · Cited by 18

Hypersensitivity to rapamycin of BJAB B lymphoblastoid cells.

Kay, J. E., Smith, M. C., Frost, V. J., & Morgan, G. Y. (1996) · PubMed Central · Cited by 15

Targeted therapies for kidney cancer in urologic practice

Haas, N. B., & Uzzo, R. G. (2007) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2007.05.009 · Cited by 14

Branched‐chain amino acid synthesis is coupled to TOR activation early in the cell cycle in yeast

Blank, H. M., Reuse, C., Schmidt‐Hohagen, K., Hammer, S. E., Hiller, K., & Polymenis, M. (2023) · EMBO Reports · doi:10.15252/embr.202357372 · Cited by 11

Emerging strategies for the clinical application of rapamycin

Kahan, B. D. (1998) · Clinical Biochemistry · doi:10.1016/s0009-9120(98)00044-7 · Cited by 12

Adjuvant therapy for renal cell carcinoma

Haas, N. B., & Uzzo, R. G. (2008) · Current Oncology Reports · doi:10.1007/s11912-008-0037-4 · Cited by 12

Rapamycin induces autophagy and apoptosis in Kaposiform hemangioendothelioma primary cells in vitro

Wang, Z., Han, Q., Wang, J., Yao, W., Wang, L., & Li, K. (2022) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2022.02.032 · Cited by 11

Candidate genes for multiple endocrine neoplasia type 1

Lagercrantz, J., Larsson, C., Grimmond, S. M., Skogseid, B. M., Gobl, A., Friedman, E., Carson, E., Phelan, C., Öberg, K., Nordenskjöld, M., et al. (1995) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1995.tb00930.x · Cited by 11

Tyrosine Kinase Inhibitors and Anti-Angiogenic Therapies in Kidney Cancer

Haas, N. B., & Uzzo, R. G. (2007) · Current Treatment Options in Oncology · doi:10.1007/s11864-007-0031-3 · Cited by 10

Probing T-cell signal transduction pathways with the immunosuppressive drugs, FK-506 and rapamycin

Siekierka, J. J. (1994) · Immunologic Research · doi:10.1007/bf02918272 · Cited by 10

Influence of various growing substrates on growth and flowering of potted miniature rose cultivar "Baby Boomer"

Younis, A., Riaz, A., Javaid, F., Ahsan, M. T., Tariq, U., Aslam, S., & Asif, M. (2015) · Time to knit · doi:10.51847/vulzsqgqhh · Cited by 9

Divergence in Signaling Pathways Involved in Promotion of Cell Viability Mediated by bFGF, NGF, and EGF in PC12 Cells

Kawamata, T., Yamaguchi, T., Shin‐ya, K., & Hori, T. (2003) · Neurochemical Research · doi:10.1023/a:1024284529945 · Cited by 9

A novel ring contraction of rapamycin

Nelson, F. C., Stachel, S. J., & Mattes, J. F. (1994) · Tetrahedron Letters · doi:10.1016/s0040-4039(00)78342-0 · Cited by 8

Tacrolimus and Other Immunosuppressive Macrolides in Clinical Practice

Amaya, T., Hiroi, J., & Lawrence, I. D. (2003) · Elsevier eBooks · doi:10.1016/b978-012526451-8/50010-2 · Cited by 8

The mTOR Pathway and Aging

Schreiber, K. H., O’Leary, M. N., & Kennedy, B. K. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-411596-5.00002-2 · Cited by 7

Cell synchronization by Rapamycin improves the developmental competence of buffalos (Bubalus bubalis) somatic cell nuclear transfer embryos

Xu, J., Shi, P., Zhao, X., Shen, P., Feng, Y., Lu, F., & Shi, D. (2020) · Reproduction in Domestic Animals · doi:10.1111/rda.13868 · Cited by 6

Produtos Naturais em Fase Avançada de Testes Clínicos no Tratamento contra o Câncer

Souza, M. V. N. D., Pinheiro, A., Ferreira, M. L., Gonçalves, R. S. B., & Lima, C. H. D. C. (2007) · Revista Fitos · doi:10.32712/2446-4775.2007.72 · Cited by 6

The usage of alternative splice sites in mus musculus synaptotagmin-like 2 gene is modulated by cyclosporin A and FK506 in T-lymphocytes

Mascarell, L., Auger, R., Kanellopoulos, J., & Truffa‐Bachi, P. (2006) · Molecular Immunology · doi:10.1016/j.molimm.2005.10.019 · Cited by 4

Pharmacologic Immunosuppressants in Xenotransplantation

Brazelton, T. R., Cheung, A., & Morris, R. E. (1997) · Springer eBooks · doi:10.1007/978-3-642-60572-7_44 · Cited by 4

Ionizing radiation enhances double-strand-break repair in rapamycin-treated ataxia telangiectasia lymphoblasts

Sikpi, M. O. (2000) · International Journal of Radiation Biology · doi:10.1080/095530000138835 · Cited by 4

Evolving role of sirolimus immunosuppression after organ transplantation

Formica, R. N., Friedman, A. L., & Lorber, M. I. (2002) · Current Opinion in Organ Transplantation · doi:10.1097/00075200-200212000-00009 · Cited by 4

Revisªo/AtualizaÁªo em Transplante Renal: Novos agentes imunossupressores

Abbud‐Filho, M., & Ramalho, H. J. (1997) · Cited by 3

Induced Dimerization Tools to Deplete Specific Phosphatidylinositol Phosphates

Pacheco, J. E., Wills, R. C., & Hammond, G. R. V. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1142-5_7 · Cited by 3

Bacterial Attenuation and its Link to Innate Oncolytic Potential: Implications for Creation and the Fall

Kim, L. (2008) · Cited by 2

The Role of Target of Rapamycin Signaling in Tuberous Sclerosis Complex

Manning, B. D. (2010) · Wiley eBooks · doi:10.1002/9783527630073.ch6 · Cited by 2

Targeting the mammalian target of rapamycin pathway in osteosarcoma using combinative chemotherapy

Liu, P., Zhang, W., & Wei, Y.-Y. (2013) · Chinese Medical Journal · doi:10.3760/cma.j.issn.0366-6999.20112107 · Cited by 1

Methods of karyoplast cell cycle synchronization for increasing the efficiency of somatic cloning of farm animals

Zhukova, Z. A. С. (2024) · Genes and Cells · doi:10.17816/gc630218 · Cited by 1

NATURAL REMEDIES WITH POTENTIAL ANTI-CANCER ACTIVITY AND ROLE OF PLANT TISSUE CULTURE IN DEVELOPMENT OF THOSE REMEDIES: A REVIEW

Pandey, A., & Tripathi, S. (2014) · International Research Journal of Pharmacy · doi:10.7897/2230-8407.050206 · Cited by 1

The Role of mTOR Inhibitors and PI3K Pathway Blockade in Renal Cell Cancer

Dorff, T. B., & Mack, P. C. (2015) · Springer eBooks · doi:10.1007/978-3-319-17903-2_18 · Cited by 1

The PI3K-mTOR Pathway

Thomas, H. E., Veiga, S. R., Thomas, G., & Kozma, S. C. (2015) · Springer eBooks · doi:10.1007/978-2-8178-0492-7_2 · Cited by 1

The TGFβ receptors and signaling pathways

Datto, M., Bassing, C. H., & Wang, X. (1996) · Growth factors and cytokines in health and disease · doi:10.1016/s1874-5687(96)80017-6 · Cited by 1

Studies on the PI3K/mTOR pathway as cytostatic treatment target in pituitary adenomas

Cerovac, V. (2010) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.11932 · Cited by 1

Multiple outcomes for PI3K/Akt/mTOR targeting in non-Hodgkin lymphoma

Müller, A. (2015) · edoc Publication server (Humboldt University of Berlin) · doi:10.18452/17284 · Cited by 1

Mammalian Target of Rapamycin in Renal Cell Carcinoma

Jonasch, E., & Choueiri, M. (2012) · Humana Press eBooks · doi:10.1007/978-1-62703-062-5_18

Synthetic Beta-Lactam Antibiotics as a Selective Breast Cancer Cell Apoptosis Inducer: Significance in Breast Cancer Prevention and Treatment

Dou, Q. P. (2007) · doi:10.21236/ada572620

Examination of Potential Anti-Tumor Activity of N-Thiolated b-Lactam Antibiotics in Nude Mice Bearing Human Breast Tumors

Dou, Q. P. (2006) · Defense Technical Information Center (DTIC)

Rapamycin antagonizes interleukin-6 mediated growth arrest and differentiation of myeloblastic M1 cells

Kloke, O., Kummer, G., & Seeber, S. (1997) · Immunology Letters · doi:10.1016/s0165-2478(97)00110-7

Recent advances in immunosuppression

Woude, A. C. V., & Bierer, B. E. (1995) · Seminars in Anesthesia Perioperative Medicine and Pain · doi:10.1016/s0277-0326(05)80011-x

The Role of mTOR Inhibitors and P13K Pathway Blockade in RCC

Choueiri, M., & Mack, P. C. (2011) · Springer eBooks · doi:10.1007/978-3-642-21858-3_14

Identification of Novel Cell Cycle Targets Using Small Molecule Ligands

Berlin, V., & Chiu, M. I. (1996) · Springer eBooks · doi:10.1007/978-3-642-57783-3_13

Data from The Somatostatin Analogue Octreotide Confers Sensitivity to Rapamycin Treatment on Pituitary Tumor Cells

Cerovac, V., Garcia, J. L. M., Rubinfeld, H., Buchfelder, M., Losa, M., Florio, T., Páez-Pereda, M., Stalla, G. K., & Theodoropoulou, M. (2023) · doi:10.1158/0008-5472.c.6500775

The synergistic tumor suppressor effect of CDK4/6 inhibitors and BRD4 inhibitors in acute myeloid leukemia

Liao, K., Guo, C., Zhang, M., Lv, X., & Yan, J. (2025) · Leukemia Research Reports · doi:10.1016/j.lrr.2025.100558

BindingDB Entry 50033698: Design and evaluation of 3-aminopyrazolopyridinone kinase inhibitors inspired by the natural product indirubin.

BindingDB (2012) · UC San Diego · doi:10.7270/q22807zf

Untitled work

(2011) · International Journal of Phytomedicine · Cited by 203

A mammalian protein targeted by G1-arresting rapamycin–receptor complex

Brown, E. J., Albers, M. W., Bum Shin, T., ichikawa, K., Keith, C. T., Lane, W. S., & Schreiber, S. L. (1994) · Nature · doi:10.1038/369756a0 · Cited by 2,053

Rapamycin-FKBP12 blocks proliferation, induces differentiation, and inhibits cdc2 kinase activity in a myogenic cell line.

Jayaraman, T., & Marks, A. R. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74403-2 · Cited by 101

The FKBP12-Rapamycin-binding Domain Is Required for FKBP12-Rapamycin-associated Protein Kinase Activity and G1 Progression

Vilella-Bach, M., Nuzzi, P., Fang, Y., & Chen, J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.7.4266 · Cited by 154

An FKBP‐Rapamycin‐Sensitive, Cyclin‐Dependent Kinase Activity that Correlates with the FKBP‐Rapamycin‐Induced G1 Arrest Point in MG‐63 Cellsa

Albers, M. W., Brown, E. J., Tanaka, A., Williams, R. T., Hall, F. L., & Schreiber, S. L. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb17142.x · Cited by 16

Rapamycin inhibits cdk4 activation, p 21WAF1/CIP1 expression and G1‐phase progression in transformed mouse fibroblasts

Gaben, A., Saucier, C., Bedin, M., Barbu, V., & Mešter, J. (2003) · International Journal of Cancer · doi:10.1002/ijc.11521 · Cited by 35